Cargando…

Role of heparanase in pulmonary hypertension

Pulmonary hypertension (PH) is a pathophysiological condition of increased pulmonary circulation vascular resistance due to various reasons, which mainly leads to right heart dysfunction and even death, especially in critically ill patients. Although drug interventions have shown some efficacy in im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lin-Jun, Feng, Fei, Li, Jian-Chun, Chen, Ting-Ting, Liu, Li-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450954/ https://www.ncbi.nlm.nih.gov/pubmed/37637421 http://dx.doi.org/10.3389/fphar.2023.1202676

Ejemplares similares

Role of heparanase in ARDS through autophagy and exosome pathway (review)
por: Feng, Fei, et al.
Publicado: (2023)

Role of heparanase in sepsis‑related acute kidney injury (Review)
por: Li, Jian-Chun, et al.
Publicado: (2023)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis
por: Chen, Ting-Ting, et al.
Publicado: (2023)

Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development
por: Kaltenbach, Dominik D., et al.
Publicado: (2018)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
por: Buijsers, Baranca, et al.
Publicado: (2023)

Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

The Role of Heparanase in Pulmonary Cell Recruitment in Response to an Allergic but Not Non-Allergic Stimulus
por: Morris, Abigail, et al.
Publicado: (2015)

Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension
por: Liu, Yan, et al.
Publicado: (2022)

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
por: Shu, Tingting, et al.
Publicado: (2021)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
por: Xue, Zhifeng, et al.
Publicado: (2021)

Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Zhang, Min, et al.
Publicado: (2019)

Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis
por: Zhang, Ruihua, et al.
Publicado: (2022)

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)
por: Luo, Jun, et al.
Publicado: (2023)

Heparanase Modulates Chromatin Accessibility
por: Li, Honglian, et al.
Publicado: (2023)

The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study
por: Chen, Yusi, et al.
Publicado: (2022)

Role of heparanase 2 (Hpa2) in gastric cancer
por: Liu, Jingjing, et al.
Publicado: (2021)

Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases
por: Zcharia, Eyal, et al.
Publicado: (2009)

Leflunomide-induced pulmonary arterial hypertension in a young man with nephrotic syndrome: A case report
por: Luo, Xiaoqin, et al.
Publicado: (2022)

Therapeutic Strategies in Pulmonary Hypertension
por: Fuso, Leonello, et al.
Publicado: (2011)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
por: Li, Huayang, et al.
Publicado: (2021)

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
por: Chen, Yusi, et al.
Publicado: (2022)

Emerging Roles of Heparanase in Viral Pathogenesis
por: Thakkar, Neel, et al.
Publicado: (2017)

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
por: Tettey, Abraham, et al.
Publicado: (2021)

Advances in the research of sulfur dioxide and pulmonary hypertension
por: Liu, Xin, et al.
Publicado: (2023)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
por: Shi, Yinan, et al.
Publicado: (2021)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Extract of Plantago asiatica L. Seeds Ameliorates Hypertension in Spontaneously Hypertensive Rats by Inhibition of Angiotensin Converting Enzyme
por: Tong, Ren-Chao, et al.
Publicado: (2019)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis
por: Xiao, Xinghua, et al.
Publicado: (2022)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension
por: Jasemi, Seyed Vahid, et al.
Publicado: (2020)

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
por: Zhang, Hui, et al.
Publicado: (2021)

Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases
por: Li, Yi-Xuan, et al.
Publicado: (2022)

Supplementation with Tex261 provides a possible preventive treatment for hypoxic pulmonary artery hypertension
por: Chen, Shaokun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvss8o7ukg95nsb3dts4n6ppsb